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An association between inhaled particulate
matter and increased mortality/morbidity has
been well documented by epidemiologic
studies (1,2), with the cardiovascular system
as the main target (3,4). Recent experimental
studies using concentrated ambient particles
showed cardiac effects in dogs (5). Of the
particulate matter in the ambient air, Seaton
et al. (6) have suggested that ultraﬁne (< 100
nm) particles are the main cause for cardio-
vascular disorders. Materials such as an ele-
mental carbon found in flames or metallic
vapor formed during combustion are likely
candidates for solid ultraﬁne particles (7).
Several mechanisms linking the cardio-
vascular disorders to inhaled particles have
been hypothesized but remain to be veriﬁed.
In addition to autonomic or cytokine-medi-
ated effects, direct interaction of inhaled
materials with the target tissue must be
examined to understand the underlying
mechanism (5,8,9). Pulmonary retention
and systemic redistribution of inhaled parti-
cles may be important contributing factors.
It has been reported that inhaled or intratra-
cheally instilled ultrafine particles of iron
oxide, India ink, or titanium dioxide were
found mainly in alveolar macrophages
(10–14). It is possible that the particles can
also enter the alveolar wall and lung-associ-
ated lymph nodes (10–14). A potential arti-
fact in these studies is that the ultrafine
particles were either suspensions (intra-
tracheal instillation study) or administered
at high aerosol concentrations (8–200
mg/m3), which promoted particle coagula-
tion and resulted in larger agglomerated par-
ticles (15). Such agglomerated particles as
well as particles > 100 nm will be readily
phagocytized by alveolar macrophages (16).
Consequently, alveolar macrophages play a
key role in the fate of these larger particles.
However, it is currently speculated that
ultrafine particles may not be readily
detected and phagocytized by alveolar
macrophages in the alveolar region. Instead,
these ultrafine particles may directly enter
the alveolar wall and subsequently the
systemic circulation. 
Test particles made of elemental silver
(EAg) may be suitable for investigating the sys-
temic distribution of ultraﬁne particles, as EAg
is considered inert and not rapidly dissolved
(17–19). In other studies iron oxide particles
were used for similar purposes (10); however,
unlike iron oxide the natural content of Ag in
laboratory animals is negligible. Because the
detection limit for Ag is 10 ng/L by induc-
tively coupled plasma mass spectrometry
(ICP–MS) analysis (20,21), the Ag content in
the lung and other organs such as the heart can
be analyzed even after exposure to low concen-
trations relevant to the environment. Our pre-
vious study showed that agglomerated EAg
particles were morphologically visible for at
least 7 days in both macrophage-like J774
cells (in vitro study) and the rat lung after
intratracheal instillation (22). Therefore, EAg
remains essentially undissolved during this
time, and EAg particles can be used to mimic
the distribution pattern of ambient solid
ultraﬁne particles. 
In this article, we present results on the
pulmonary and systemic distribution of EAg
after inhalation at a relatively low concentra-
tion based on morphology and the ICP–MS
analysis. In addition, instilled agglomerated
EAg particles and water-soluble silver nitrate
(AgNO3) were also used for comparison
purposes.
Materials and Methods
Generation of Ultraﬁne Particles
Ultrafine EAg particles were generated by
spark discharging through an argon atmos-
phere (model GFG 1000, Palas, Karlsruhe,
Germany) (23). The size distribution and the
number concentration were measured with a
differential mobility analyzer (model EMS
150, Hauke, Gmunden, Austria) and a con-
densation nucleus counter (model 3022A,
TSI, St. Paul, USA). The particles were either
used immediately for inhalation exposure or
collected on polytetraﬂuroethylene ﬁlters (pore
size 0.2 µm; Sartorius, Goettingen, Germany)
for subsequent intratracheal instillation.
Animals
Female Fischer 344 rats (body weight
150–200 g) were obtained from Charles
River (Sulzfeld, Germany) and housed in an
animal facility under filtered air (22 ± 2°C,
50 ± 5% relative humidity). They received a
standard pellet diet and water ad libitum. 
This study was conducted under federal
guidelines for the use and care of laboratory
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animals and was approved by the Government
of the District of Upper Bavaria and by the
animal care and use committee of this
research center.
Inhalation Exposure
Sixteen animals were exposed to ultrafine
EAg particles in whole body chambers (330 L
in volume for 16 rats, laminar horizontal
flow, ventilation exchange rate of 20
times/hr) for 6 hr at a mass concentration of
133 µg Ag m3 and a particle number concen-
tration of 3 × 106 cm3 (24). The modal
diameter of the number size distribution was
14.6 ± 1.0 nm, median 17.1 ± 1.2 nm, and
geometric standard deviation 1.38. The esti-
mated total inhaled cumulative dose was 7.2
µg according to the formula of delivered dose
(25,26). Four rats each were sacrificed on
days 0, 1, 4, and 7 after the exposure for mor-
phology and elemental analysis. Eight animals
were exposed to clean air in another whole
body chamber and served as controls.
Intratracheal Instillation
For comparison purposes, rats received either
150 µL aqueous solution of 7 µg AgNO3 (4.4
µg Ag) (12 animals) or 150 µL aqueous suspen-
sion of 50 µg EAg (7 animals) by intratracheal
instillation. Two to 4 rats each were sacriﬁced
on days 1, 4, and 7 after instillation, and mor-
phology and elemental analysis performed.
Morphology
The ultrastructure of the Ag particles collected
from the inhalation exposure air stream or the
instillation aqueous suspension was examined
by a transmission electron microscope. Left
lobes of the lungs were ﬁxed with 2.5% glu-
taraldehyde, pH 7.4, 340 mOsm in sodium
potassium buffer under 25 cm pressure. Small
samples were re-fixed with 1% osmium
tetraoxide, dehydrated with serial alcohol and
propylene oxide, and embedded in Epon.
Semithin sections were stained with toluidine
blue, ultrathin sections with uranyl acetate
and with or without lead citrate.
ICP–MS Analysis
Ag was quantified by ICP–MS (Element,
Finnigan MAT, Germany) after pressurized
digestion of tissue samples with nitric acid
(HNO3). The following tissues/organs were
analyzed: blood from the abdominal aorta;
heart, LALNs (lung associated-lymph nodes,
i.e., tracheobronchial and mediastinal lymph
nodes); lung (right caudal lobe); liver (middle
lobe); kidney; nasal cavity (anterior portion,
i.e., nasal- and maxilloturbinates plus epithe-
lia of septum and lateral wall; posterior por-
tion, i.e., ecto- and endoturbinates and
epithelia of the septum); and brain (olfactory
portion, i.e., olfactory bulb and surrounding
tissues, and the rest). 
Statistical Analysis
Clearance rates of Ag in the EAg inhalation
group and AgNO3 instillation group were
compared statistically using the Mann
Whitney U-test.
Results 
Particle Morphology
The ultrastructure of EAg particles collected
from the air stream (aerosol) and the aqueous
suspension is shown in Figures 1 and 2.
Almost all EAg particles were compact,
spherical, and electron-dense particles with
diameters of 4–10 nm. Thus, the aerosol was
composed entirely of ultraﬁne particles. In the
aqueous EAg suspension, agglomerated parti-
cles larger than 100 nm were dominant, but
ultraﬁne particles were also seen. High magni-
fication revealed that the agglomerates were
composed of ultraﬁne particles that were very
similar in shape and size to those inhaled. 
Inhalation Studies
Rats were exposed for 6 hr at a concentration
of 133 µg EAg m3. Morphologic analysis
showed no accumulation of particle-laden
alveolar macrophages. Investigation of several
tissue sections with or without contrast by
lead citrate showed no EAg particles in the
lung. The Ag concentrations and content in
the main organs on days 0, 1, 4 and 7 are
shown in Table 1. Ag in the lungs decreased
rapidly with time, and by day 7 only 4% of
the initial burden remained. In the blood, the
Ag concentration was 8.9 ng/g on day 0, and
thereafter decreased rapidly. At each time
point 9–21% of lung content was observed in
the liver. In the other organs, low concentra-
tions of Ag were detected. Nasal cavities, espe-
cially the posterior portion, and the LALNs
showed relatively high concentrations of Ag.
Instillation Studies
In order to determine the persistence of parti-
cles in the lung, rats receiving aqueous sus-
pensions of EAg or aqueous solutions of
AgNO3 by intratracheal instillation were
examined. As shown in Figure 3, accumula-
tion of particle-laden alveolar macrophages
was observed even at 4 and 7 days after the
instillation of EAg. In addition, the particles
were seen within the alveolar walls.
Ultrastructurally, EAg particles were located
in the phagolysosomes of the alveolar
macrophages (Figure 4A). At a high magniﬁ-
cation both agglomerated and separate ultra-
fine particles were detectable in the Figure 1. Ultrastructure of EAg-aerosols. Bar = 50 nm.
Figure 2. (A) Ultrastructure of EAg-suspension. Bar = 50 nm. (B) Higher magniﬁcation of A. Bar = 10 nm. Distribution pattern of inhaled ultraﬁne Ag
phagolysosome (Figure 4B). Elemental analysis
showed that 9–16 µg of the 50 µg EAg
instilled was retained in the lung on day 1. By
day 7, the content of Ag was almost
unchanged (Table 2). A portion of the
agglomerated EAg particles remained undis-
solved in the target tissue for at least 7 days.
In contrast, rapid clearance of instilled
water-soluble AgNO3 from the lung was
observed (Table 3). Nevertheless, the clear-
ance rate from days 1–7 in this group is sig-
nificantly slower than that in the EAg
inhalation group (Figure 5). 
Discussion
This study shows that particle size and the
tendency of particles to form agglomerates
affect the distribution pathway in the lungs.
In the alveolar region, inhaled fine particles
(> 100 nm) are readily phagocytized by alveo-
lar macrophages. Consequently, alveolar
macrophages play a key role in the fate of
such particles. The total elimination of fine
particles from the alveolar region may take
place through three major routes: a) elimina-
tion of particles through the tracheobronchial
tree, with subsequent ingestion into gastroin-
testinal tract and excretion with the feces; b)
translocation of particles into lymph nodes;
and c) dissolution of particles with subse-
quent transfer of the material into the blood
(16,27). For relatively insoluble particles, the
elimination is a slow process even in small
rodents (28). Our results show that instilled
agglomerated particles were morphologically
detectable in the lung. Most instilled particles
were phagocytized by alveolar macrophages.
Particles were also frequently found in the
alveolar walls. These findings are consistent
with those of other studies involving exposure
to agglomerated ultraﬁne particles by intratra-
cheal instillation (12,29) and by inhalation of
high concentrations (11,13,14). In a pro-
longed inhalation study, the disaggregation of
phagocytized particles has been suggested as
the cause for particles entering the alveolar
wall (13,30). Although 50 µg Ag was instilled
intratracheally, the Ag content in the lung
decreased to approximately 10 µg by day 1.
In addition to direct return from the trachea
and mucociliary clearance of agglomerates
deposited in the nonalveolar region, fast
removal of ultraﬁne particles may be the rea-
son for the observed rapid clearance of Ag.
The remaining agglomerates were then
phagocytized by alveolar macrophages and
stayed in the lung for at least 7 days. 
After inhalation of a low concentration of
ultraﬁne EAg particles, we found a signiﬁcant
Ag content not only in the lung but also
other organs such as the heart. A significant
amount of Ag was also detected in the blood,
which shows that systemic distribution
occurred. After inhalation, rapid clearance of
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Figure 3. Lungs of a rat receiving 50 µg EAg particles by intratracheal instillation on (A) day 4 and (B) day 7. Circles are agglomerated particles in alveolar macrophages (small cir-
cles) and the alveolar wall (large circles). Photomicrographs are of semithin sections stained with toluidine blue. Bar = 19 µm.
Table 1. Ag concentrations and estimated content in tissues/organs of rats exposed to ultraﬁne EAg particles for 6 hr.a
Time after exposure
Immediately 
Tissues/organs (30 min–2 hr) Day 1 Day 4 Day 7
Lung Concentrationb 2,375(171) 904(31) 199(41) 98(19)
Contentc 1,716(169) 656(31) 152(35) 75(14)
Liver Concentration 33(13) 24(5.1) 5.6(1.8) 3.0(1.1)
Content 156(60) 113(24) 29(10) 16(7)
Kidney Concentration ND 39(8.1) 4.7(4.4) ND
Content ND 45(10) 5(5) ND
Heart Concentration ND 2.8(0.5) 0.7(0.1) ND
Content ND 1.5(0.3) 0.4(0.1) ND
LALN (tracheobronchial  Concentration ND 21(7.7) 72(63) ND
lymph nodes)  Content ND 0.6(0.3) 1.7(1.4) ND
LALN (mediastinal tissues  Concentration ND 6.8(0.7) 1.6(0.1) ND
including mediastinal  Content ND 2.1(0.4) 0.5(0.1) ND
lymp nodes)
Nasal cavity, anterior Concentration 59.2(22.6) 13.9(2.2) ND ND
Content 13(6.5) 1.8(0.5) ND ND
Nasal cavity, posterior Concentration 96(20.4) 68.3(4.5) ND ND
Content 16.3(5.6) 8.8(1.3) ND ND
Brain olfactory portion Concentration 1.9(1.1) 3.1(1.3) ND ND
Content 0.3(0.02) 0.4(0.2) ND ND
Brain rest Concentration 1.4(0.5) 1.2(0.2) ND ND
Content 1.6(0.6) 1.3(0.1) ND ND
Blood Concentration 8.9(6.2) 6.2(0.8) 2.9(1.5) 1.0(0.2)
Unexposed 
Lung Concentration < 1.2(0.2) 
Content <  0.9(0.1)
Blood Concentration < 0.6(0.1)
ND, not done. 
an = 4 for each examination (for unexposed lungs n = 8). bConcentration: ng/g wet weight, mean (SD). cEstimated content: concentra-
tion × organ weight; ng, mean (SD).Ag from the lung was observed. A possible
mechanism for the fast clearance is as follows:
Whereas agglomerated EAg particles remain
undissolved in alveolar macrophages, ultraﬁne
EAg particles are dissolved rapidly in the lung
and Ag enters the blood capillaries by diffu-
sion (31–33). We found that instilled water-
soluble AgNO3 was cleared rapidly from the
lung, which supports the theory of rapid solu-
bilization of ultrafine EAg in the lung.
Nevertheless, the clearance rate for the
AgNO3 instillation group from days 1–7 was
lower than that for the EAg inhalation group.
The retardation of AgNO3 clearance may
partly be due to the binding affinity of Ag
ions onto proteins. After ingestion of AgNO3
in drinking water or intravenous injection, Ag
was detected in the cellular component/base-
ment membrane in the tissues (34,35). In our
study a portion of instilled Ag may have com-
bined with cellular components in the lung
with subsequent retention. As we have no evi-
dence on the binding of Ag in the lung in this
experiment, further study is required. 
However, another mechanism for rapid
clearance of inhaled EAg may also be possi-
ble. Ultrafine particles entering the alveolar
wall might gain access to the blood capillaries.
In this case, no prior dissolution process is
necessary. Morrow (31), Stradling et al. (36),
Raabe (37), and Ferin et al. (14) proposed
that the blood capillaries are a likely clearance
route for ultrafine particles. Previous studies
showed that instilled colloidal carbon parti-
cles (30-nm diameter for primary particles)
have been found in alveolar macrophages,
alveolar type I cells, and the septal intersti-
tium but not in blood capillaries (12,29).
However, Stearns et al. (38), using analytical
electron microscopy, demonstrated an
unusual presence of ultrafine copper oxide
particles in the septal blood capillaries.
Kanapilly et al. (39) found a difference in
pulmonary deposition and retention between
20-nm gallium oxide aerosols and 100-nm
aggregates of the same material. In their study
20-nm particles were cleared more rapidly
from the lung than 100-nm particles. The
authors commented that because the same
primary size of the same material was used in
the study, the different clearance could not be
explained by a difference in solubility and
therefore was due to unknown mechanisms.
A possible explanation for their results is that
because of their very small size, the ultraﬁne
particles were not efﬁciently phagocytized by
macrophages and instead were cleared rapidly
through the circulatory system. 
In the future, ultraﬁne particles with other
properties, e.g., solubility, size or binding afﬁn-
ity, must be used in studies to further under-
stand the fate of inhaled ultraﬁne particles. 
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